Search - tctmd.com

Displaying 41 - 60 of 719

Sort: Relevancy | Date

News Daily News

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

Michael O'Riordan

November 28, 2018

Top Stories in Cardiology: November 2018

Podcast Heart Sounds

Aspirin Should Play Limited Role in Primary Prevention: Review

Michael O'Riordan

November 27, 2018

News Daily News

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

L.A. McKeown

November 27, 2018

News Daily News

Higher Rates of Amputation and Ketoacidosis With SGLT2 Inhibitors: European Registry Data

Michael O'Riordan

November 26, 2018

News Daily News

PIONEER 6: Oral Semaglutide Passes Test in Cardiovascular Outcomes Study

Michael O'Riordan

November 23, 2018

News Daily News

Certain Risk Factors Carry Higher MI Risk in Women Than in Men

Shelley Wood

November 23, 2018

News Daily News

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

Michael O'Riordan

November 23, 2018

News Daily News

Female Cardiologists and Interventionalists Rare, Isolated in Australia and New Zealand

Shelley Wood

November 22, 2018

News Daily News

Bullying or Violence on the Job May Boost CVD Risk

Todd Neale

November 22, 2018

News Daily News

Obesity Causally Linked to CAD but Not Stroke, Meta-analysis Hints

Caitlin E. Cox

November 21, 2018

News Daily News

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Michael O'Riordan

November 20, 2018

News Daily News

Frailty Linked to Higher Bleeding Risk Among Acute MI Patients Undergoing PCI

L.A. McKeown

November 19, 2018

News Conference News AHA 2018

Concerning Decline in Antibiotic Prophylaxis for Infective Endocarditis

Todd Neale

November 19, 2018

News Daily News

FDA Allows Claim About Oleic Acid’s Possible Heart Benefits on Labeling

Todd Neale

November 19, 2018

News Conference News AHA 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Michael O'Riordan

November 16, 2018

News Conference News AHA 2018

EWTOPIA 75: Ezetimibe Bests Dietary Counseling Alone in Lowering Cardiovascular Risk for Elderly Japanese Patients

Yael L. Maxwell

November 16, 2018

News Opinion Conversations in Cardiology

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

November 16, 2018

News Daily News

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

Caitlin E. Cox

November 15, 2018

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

Advertisement

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

Top Stories in Cardiology: November 2018

Aspirin Should Play Limited Role in Primary Prevention: Review

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

Higher Rates of Amputation and Ketoacidosis With SGLT2 Inhibitors: European Registry Data

PIONEER 6: Oral Semaglutide Passes Test in Cardiovascular Outcomes Study

Certain Risk Factors Carry Higher MI Risk in Women Than in Men

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

Female Cardiologists and Interventionalists Rare, Isolated in Australia and New Zealand

Bullying or Violence on the Job May Boost CVD Risk

Obesity Causally Linked to CAD but Not Stroke, Meta-analysis Hints

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Frailty Linked to Higher Bleeding Risk Among Acute MI Patients Undergoing PCI

Concerning Decline in Antibiotic Prophylaxis for Infective Endocarditis

FDA Allows Claim About Oleic Acid’s Possible Heart Benefits on Labeling

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

EWTOPIA 75: Ezetimibe Bests Dietary Counseling Alone in Lowering Cardiovascular Risk for Elderly Japanese Patients

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content